WO2003042150A1 - Nouveaux derives de benzophenone ou sels de ceux-ci - Google Patents
Nouveaux derives de benzophenone ou sels de ceux-ci Download PDFInfo
- Publication number
- WO2003042150A1 WO2003042150A1 PCT/JP2002/011846 JP0211846W WO03042150A1 WO 2003042150 A1 WO2003042150 A1 WO 2003042150A1 JP 0211846 W JP0211846 W JP 0211846W WO 03042150 A1 WO03042150 A1 WO 03042150A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- salts
- optionally
- remedies
- arthritis
- useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
- C07C205/34—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups bound to carbon atoms of six-membered aromatic rings and etherified hydroxy groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/76—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings and etherified hydroxy groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/10—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/62—Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
- C07C271/64—Y being a hydrogen or a carbon atom, e.g. benzoylcarbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
- C07C65/34—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
- C07C65/40—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
- C07C69/88—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with esterified carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/94—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
Priority Applications (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ532810A NZ532810A (en) | 2001-11-16 | 2002-11-13 | Novel bensophenone derivatives or salts thereof |
BR0214177-9A BR0214177A (pt) | 2001-11-16 | 2002-11-13 | Derivado de benzofenona, agente preventivo ou terapêutico para uma doença em que está envolvida expressão excessiva de ap-1, e, inibidor de ap-1 |
JP2003543987A JP4554926B2 (ja) | 2001-11-16 | 2002-11-13 | 新規なベンゾフェノン誘導体またはその塩 |
AU2002349777A AU2002349777B2 (en) | 2001-11-16 | 2002-11-13 | Novel benzophenone derivatives or salts thereof |
US10/493,223 US7772285B2 (en) | 2001-11-16 | 2002-11-13 | Benzophenone derivatives or salts thereof |
MXPA04004654A MXPA04004654A (es) | 2001-11-16 | 2002-11-13 | Novedosos derivados de benzofenona o sus sales. |
EP02781763A EP1445249B1 (en) | 2001-11-16 | 2002-11-13 | Novel bensophenone derivatives or salts thereof |
IL16173602A IL161736A0 (en) | 2001-11-16 | 2002-11-13 | Novel benzophenone derivatives or salts thereof |
ROA200400442A RO123430B1 (ro) | 2001-11-16 | 2002-11-13 | Derivaţi noi de benzofenonă sau sărurile acestora |
CN028248120A CN1602291B (zh) | 2001-11-16 | 2002-11-13 | 新二苯甲酮衍生物或其盐 |
DK02781763.4T DK1445249T3 (da) | 2001-11-16 | 2002-11-13 | Nye bensophenon-derivater eller salte deraf |
ES02781763T ES2394963T3 (es) | 2001-11-16 | 2002-11-13 | Nuevos derivados de benzofenona o sales de los mismos |
HU0402025A HUP0402025A3 (en) | 2001-11-16 | 2002-11-13 | Novel bensophenone derivatives or salts thereof and their use |
CA2467261A CA2467261C (en) | 2001-11-16 | 2002-11-13 | Novel benzophenone derivatives or salts thereof |
IL161736A IL161736A (en) | 2001-11-16 | 2004-05-03 | Benzophenone derivatives or salts thereof |
ZA2004/03373A ZA200403373B (en) | 2001-11-16 | 2004-05-04 | Novel benzophenone derivatives or salts thereof |
NO20042495A NO329094B1 (no) | 2001-11-16 | 2004-06-15 | Bensofenonderivater eller salter derav samt forebyggende eller terapeutisk middel inneholdende slike |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001-351217 | 2001-11-16 | ||
JP2001351217 | 2001-11-16 | ||
JP2002209382 | 2002-07-18 | ||
JP2002-209382 | 2002-07-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003042150A1 true WO2003042150A1 (fr) | 2003-05-22 |
Family
ID=26624559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2002/011846 WO2003042150A1 (fr) | 2001-11-16 | 2002-11-13 | Nouveaux derives de benzophenone ou sels de ceux-ci |
Country Status (21)
Country | Link |
---|---|
US (1) | US7772285B2 (ja) |
EP (1) | EP1445249B1 (ja) |
JP (1) | JP4554926B2 (ja) |
KR (1) | KR100947253B1 (ja) |
CN (1) | CN1602291B (ja) |
AU (1) | AU2002349777B2 (ja) |
BR (1) | BR0214177A (ja) |
CA (1) | CA2467261C (ja) |
CY (1) | CY1113657T1 (ja) |
DK (1) | DK1445249T3 (ja) |
ES (1) | ES2394963T3 (ja) |
HU (1) | HUP0402025A3 (ja) |
IL (2) | IL161736A0 (ja) |
MX (1) | MXPA04004654A (ja) |
NO (1) | NO329094B1 (ja) |
NZ (1) | NZ532810A (ja) |
PL (1) | PL206100B1 (ja) |
PT (1) | PT1445249E (ja) |
RO (1) | RO123430B1 (ja) |
WO (1) | WO2003042150A1 (ja) |
ZA (1) | ZA200403373B (ja) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005115994A1 (ja) * | 2004-05-27 | 2005-12-08 | Nihon Nohyaku Co., Ltd. | 置換ピラジンカルボン酸アニリド誘導体又はその塩類、その中間体及び農園芸用薬剤並びにその使用方法 |
JP2006008675A (ja) * | 2004-05-27 | 2006-01-12 | Nippon Nohyaku Co Ltd | 置換ピラジンカルボン酸アニリド誘導体又はその塩類、その中間体及び農園芸用薬剤並びにその使用方法 |
WO2007097279A1 (ja) * | 2006-02-21 | 2007-08-30 | Toyama Chemical Co., Ltd. | 3-{5-[4-(シクロペンチルオキシ)-2-ヒドロキシベンゾイル]-2-[(3-オキソ-2-置換-2,3-ジヒドロ-1,2-ベンズイソオキサゾール-6-イル)メトキシ]フェニル}プロピオン酸エステルの製造法およびその中間体 |
WO2007138996A1 (ja) | 2006-05-26 | 2007-12-06 | Toyama Chemical Co., Ltd. | 3-{5-[4-(シクロペンチルオキシ)-2-ヒドロキシベンゾイル]-2-[(3-ヒドロキシ-1,2-ベンズイソオキサゾール-6-イル)メトキシ]フェニル}プロピオン酸の新規な結晶 |
WO2007138997A1 (ja) | 2006-05-26 | 2007-12-06 | Toyama Chemical Co., Ltd. | 3-{5-[4-(シクロペンチルオキシ)-2-ヒドロキシベンゾイル]-2-[(3-ヒドロキシ-1,2-ベンズイソオキサゾール-6-イル)メトキシ]フェニル}プロピオン酸またはその塩を含有する経口用組成物 |
WO2009040952A1 (ja) * | 2007-09-28 | 2009-04-02 | Toyama Chemical Co., Ltd. | ベンゾフェノン誘導体またはその塩を含有する薬剤 |
WO2009069643A1 (ja) * | 2007-11-27 | 2009-06-04 | Toyama Chemical Co., Ltd. | 3-{5-[4-(シクロペンチルオキシ)-2-ヒドロキシベンゾイル]-2-[(3-ヒドロキシ-1,2-ベンズイソオキサゾール-6-イル)メトキシ]フェニル}プロピオン酸またはその塩を含有する固体分散体またはその組成物 |
WO2009119652A1 (ja) | 2008-03-27 | 2009-10-01 | 富山化学工業株式会社 | ベンゾフェノン誘導体またはその塩およびTNFα阻害剤を組み合わせて使用する方法ならびにこれらを含有する医薬組成物 |
WO2009131098A1 (ja) | 2008-04-22 | 2009-10-29 | 富山化学工業株式会社 | ベンゾフェノン誘導体またはその塩および免疫抑制剤を組み合わせて使用する方法ならびにこれらを含有する医薬組成物 |
EP2468743A1 (en) | 2005-06-24 | 2012-06-27 | Toyama Chemical Co., Ltd. | Nitrogen-containing bicyclic compounds useful as antibacterial agents |
AU2012200254B2 (en) * | 2006-02-21 | 2012-08-30 | Toyama Chemical Co., Ltd. | Process for the production of 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-oxo-2-substituted-2,3-dihydro- 1,2-benzisoxazol-6-yl)methoxy]phenyl]propionate ester and intermediate for the process |
US8592629B2 (en) | 2010-07-12 | 2013-11-26 | Pfizer Limited | Sulfonamide derivatives as Nav 1.7 inhibitors |
US8685977B2 (en) | 2010-07-12 | 2014-04-01 | Pfizer Limited | Chemical compounds |
US8772293B2 (en) | 2010-07-09 | 2014-07-08 | Pfizer Limited | Chemical compounds |
WO2014157623A1 (ja) * | 2013-03-29 | 2014-10-02 | 富山化学工業株式会社 | ベンゾフェノン誘導体またはその塩を含有する肺高血圧症治療薬 |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7615538B2 (en) * | 1993-10-29 | 2009-11-10 | Shunichi Shiozawa | Method for therapy of rheumatoid arthritis |
CN101389614B (zh) * | 2006-02-21 | 2012-10-31 | 富山化学工业株式会社 | 3-[5-[4-(环戊氧基)-2-羟基苯甲酰基]-2-[(3-氧代-2-取代的-2,3-二氢-1,2-苯并异*唑-6-基)甲氧基]苯基]丙酸酯的制备方法和用于该方法的中间体 |
EP2049510A1 (en) * | 2006-07-28 | 2009-04-22 | Krka Tovarna Zdravil, D.D., Novo Mesto | Process for the preparation of candesartan cilexetil form i |
CN100580026C (zh) * | 2007-11-01 | 2010-01-13 | 重庆大学 | 通过醚键连接的含二苯甲酮的对硝基-二苯乙烯染料及合成与应用 |
CN101225241B (zh) * | 2007-12-17 | 2010-05-26 | 重庆大学 | 非共轭型的含二苯甲酮对硝基二苯乙烯染料及其合成与应用 |
CN100580027C (zh) * | 2007-12-17 | 2010-01-13 | 重庆大学 | 通过醚键连接的含二苯甲酮的对硝基偶氮苯染料及其合成与应用 |
US8067929B2 (en) * | 2008-03-03 | 2011-11-29 | Intersil Americas, Inc. | High-side sensing of zero inductor current for step down DC-DC converter |
US20110112158A1 (en) * | 2009-11-11 | 2011-05-12 | David Robert Bolin | Benzisoxazole analogs as glycogen synthase activators |
US9096500B2 (en) | 2010-07-12 | 2015-08-04 | Pfizer Limited | Acyl sulfonamide compounds |
CA2804351A1 (en) | 2010-07-12 | 2012-01-19 | Pfizer Limited | Chemical compounds |
EP2593431B1 (en) | 2010-07-12 | 2014-11-19 | Pfizer Limited | N-sulfonylbenzamides as inhibitors of voltage-gated sodium channels |
CN103183647B (zh) * | 2011-12-28 | 2017-06-09 | 天津市国际生物医药联合研究院有限公司 | 3‑{[2‑[3‑氧‑(1,2‑苯并异噻唑‑6‑基)甲氧基‑5‑(2‑羟基‑4‑环戊氧基苯甲酰基)]苯基}丙酸的制备方法 |
US9169214B2 (en) | 2012-12-21 | 2015-10-27 | The Board Of Trustees Of The Leland Stanford Junior University | Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions |
CN106565529A (zh) * | 2015-10-13 | 2017-04-19 | 天津国际生物医药联合研究院 | 3-(2-((3-氨基甲酰基-4-羟基)苄氧基)-5-(取代苯甲酰)苯丙酸衍生物及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0276064A1 (en) * | 1987-01-12 | 1988-07-27 | Eli Lilly And Company | Anti-inflammatory agents |
WO2000027792A1 (fr) * | 1998-11-05 | 2000-05-18 | Toyama Chemical Co., Ltd. | Nouveaux composes et leur utilisation medicale |
JP2001328958A (ja) * | 2000-03-17 | 2001-11-27 | Toyama Chem Co Ltd | 新規なベンゾフェノン誘導体およびその塩 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5273999A (en) | 1991-09-10 | 1993-12-28 | Hoffmann-La Roche Inc. | Carboxylic acid leukotriene B4 antagonists |
-
2002
- 2002-11-13 DK DK02781763.4T patent/DK1445249T3/da active
- 2002-11-13 PL PL370224A patent/PL206100B1/pl unknown
- 2002-11-13 NZ NZ532810A patent/NZ532810A/en not_active IP Right Cessation
- 2002-11-13 IL IL16173602A patent/IL161736A0/xx active IP Right Grant
- 2002-11-13 MX MXPA04004654A patent/MXPA04004654A/es active IP Right Grant
- 2002-11-13 WO PCT/JP2002/011846 patent/WO2003042150A1/ja active IP Right Grant
- 2002-11-13 AU AU2002349777A patent/AU2002349777B2/en not_active Ceased
- 2002-11-13 RO ROA200400442A patent/RO123430B1/ro unknown
- 2002-11-13 ES ES02781763T patent/ES2394963T3/es not_active Expired - Lifetime
- 2002-11-13 HU HU0402025A patent/HUP0402025A3/hu unknown
- 2002-11-13 JP JP2003543987A patent/JP4554926B2/ja not_active Expired - Fee Related
- 2002-11-13 CA CA2467261A patent/CA2467261C/en not_active Expired - Fee Related
- 2002-11-13 EP EP02781763A patent/EP1445249B1/en not_active Expired - Lifetime
- 2002-11-13 US US10/493,223 patent/US7772285B2/en not_active Expired - Fee Related
- 2002-11-13 PT PT2781763T patent/PT1445249E/pt unknown
- 2002-11-13 CN CN028248120A patent/CN1602291B/zh not_active Expired - Fee Related
- 2002-11-13 BR BR0214177-9A patent/BR0214177A/pt not_active Application Discontinuation
- 2002-11-13 KR KR1020047007327A patent/KR100947253B1/ko not_active IP Right Cessation
-
2004
- 2004-05-03 IL IL161736A patent/IL161736A/en not_active IP Right Cessation
- 2004-05-04 ZA ZA2004/03373A patent/ZA200403373B/en unknown
- 2004-06-15 NO NO20042495A patent/NO329094B1/no not_active IP Right Cessation
-
2012
- 2012-11-13 CY CY20121101085T patent/CY1113657T1/el unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0276064A1 (en) * | 1987-01-12 | 1988-07-27 | Eli Lilly And Company | Anti-inflammatory agents |
WO2000027792A1 (fr) * | 1998-11-05 | 2000-05-18 | Toyama Chemical Co., Ltd. | Nouveaux composes et leur utilisation medicale |
JP2001328958A (ja) * | 2000-03-17 | 2001-11-27 | Toyama Chem Co Ltd | 新規なベンゾフェノン誘導体およびその塩 |
Non-Patent Citations (1)
Title |
---|
See also references of EP1445249A4 * |
Cited By (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006008675A (ja) * | 2004-05-27 | 2006-01-12 | Nippon Nohyaku Co Ltd | 置換ピラジンカルボン酸アニリド誘導体又はその塩類、その中間体及び農園芸用薬剤並びにその使用方法 |
WO2005115994A1 (ja) * | 2004-05-27 | 2005-12-08 | Nihon Nohyaku Co., Ltd. | 置換ピラジンカルボン酸アニリド誘導体又はその塩類、その中間体及び農園芸用薬剤並びにその使用方法 |
EP2468743A1 (en) | 2005-06-24 | 2012-06-27 | Toyama Chemical Co., Ltd. | Nitrogen-containing bicyclic compounds useful as antibacterial agents |
CN102285931A (zh) * | 2006-02-21 | 2011-12-21 | 富山化学工业株式会社 | 3-[5-[4-(环戊氧基)-2-羟基苯甲酰基]-2-[(3-氧代-2-取代的-2,3-二氢-1,2-苯并异噁唑-6-基)甲氧基]苯基]丙酸酯的制备方法和用于该方法的中间体 |
WO2007097279A1 (ja) * | 2006-02-21 | 2007-08-30 | Toyama Chemical Co., Ltd. | 3-{5-[4-(シクロペンチルオキシ)-2-ヒドロキシベンゾイル]-2-[(3-オキソ-2-置換-2,3-ジヒドロ-1,2-ベンズイソオキサゾール-6-イル)メトキシ]フェニル}プロピオン酸エステルの製造法およびその中間体 |
CN102285931B (zh) * | 2006-02-21 | 2014-01-01 | 富山化学工业株式会社 | 3-[5-[4-(环戊氧基)-2-羟基苯甲酰基]-2-[(3-氧代-2-取代的-2,3-二氢-1,2-苯并异噁唑-6-基)甲氧基]苯基]丙酸酯的制备方法和用于该方法的中间体 |
JP5236456B2 (ja) * | 2006-02-21 | 2013-07-17 | 富山化学工業株式会社 | 3−{5−[4−(シクロペンチルオキシ)−2−ヒドロキシベンゾイル]−2−[(3−オキソ−2−置換−2,3−ジヒドロ−1,2−ベンズイソオキサゾール−6−イル)メトキシ]フェニル}プロピオン酸エステルの製造法およびその中間体 |
EP2562170A1 (en) | 2006-02-21 | 2013-02-27 | Toyama Chemical Co., Ltd. | Process for production of 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-oxo-2-substituted-2,3-dihydro-1,2-benzisoxazol-6-yl)methoxy]phenyl]propionate ester and intermediate for the process |
AU2012200254B2 (en) * | 2006-02-21 | 2012-08-30 | Toyama Chemical Co., Ltd. | Process for the production of 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-oxo-2-substituted-2,3-dihydro- 1,2-benzisoxazol-6-yl)methoxy]phenyl]propionate ester and intermediate for the process |
US8153816B2 (en) | 2006-02-21 | 2012-04-10 | Toyama Chemical Co., Ltd. | Process for production of 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-OXO-2-substituted-2,3-dihydro-1,2-benzisoxazol-6-yl)methoxy]phenyl]propionate ester and intermediate for the process |
US8017789B2 (en) | 2006-02-21 | 2011-09-13 | Toyama Chemical Co., Ltd. | Process for production of 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-OXO-2-substituted-2,3-dihydro-1,2-benzisoxazol-6-yl]methoxy]phenyl]proprionate ester and intermediate for the process |
KR101389038B1 (ko) * | 2006-05-26 | 2014-04-28 | 토야마 케미칼 컴퍼니 리미티드 | 3-{5-[4-(시클로펜틸옥시)-2-하이드록시벤조일]-2-[(3-하이드록시-1,2-벤즈이소옥사졸-6-일)메톡시]페닐}프로피온산의 신규의 결정 |
WO2007138997A1 (ja) | 2006-05-26 | 2007-12-06 | Toyama Chemical Co., Ltd. | 3-{5-[4-(シクロペンチルオキシ)-2-ヒドロキシベンゾイル]-2-[(3-ヒドロキシ-1,2-ベンズイソオキサゾール-6-イル)メトキシ]フェニル}プロピオン酸またはその塩を含有する経口用組成物 |
US7977492B2 (en) | 2006-05-26 | 2011-07-12 | Toyama Chemical Co., Ltd. | Crystal of 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl]propionic acid |
WO2007138996A1 (ja) | 2006-05-26 | 2007-12-06 | Toyama Chemical Co., Ltd. | 3-{5-[4-(シクロペンチルオキシ)-2-ヒドロキシベンゾイル]-2-[(3-ヒドロキシ-1,2-ベンズイソオキサゾール-6-イル)メトキシ]フェニル}プロピオン酸の新規な結晶 |
JP5117381B2 (ja) * | 2006-05-26 | 2013-01-16 | 富山化学工業株式会社 | 3−{5−[4−(シクロペンチルオキシ)−2−ヒドロキシベンゾイル]−2−[(3−ヒドロキシ−1,2−ベンズイソオキサゾール−6−イル)メトキシ]フェニル}プロピオン酸の新規な結晶 |
US8093289B2 (en) | 2006-05-26 | 2012-01-10 | Toyama Chemical Co., Ltd. | Oral composition comprising 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl]propionic acid or salt thereof |
JP5161077B2 (ja) * | 2006-05-26 | 2013-03-13 | 富山化学工業株式会社 | 3−{5−[4−(シクロペンチルオキシ)−2−ヒドロキシベンゾイル]−2−[(3−ヒドロキシ−1,2−ベンズイソオキサゾール−6−イル)メトキシ]フェニル}プロピオン酸またはその塩を含有する経口用組成物 |
US9012482B2 (en) | 2007-09-28 | 2015-04-21 | Toyama Chemical Co., Ltd. | Drug containing benzophenone derivative or its salt |
WO2009040952A1 (ja) * | 2007-09-28 | 2009-04-02 | Toyama Chemical Co., Ltd. | ベンゾフェノン誘導体またはその塩を含有する薬剤 |
WO2009069643A1 (ja) * | 2007-11-27 | 2009-06-04 | Toyama Chemical Co., Ltd. | 3-{5-[4-(シクロペンチルオキシ)-2-ヒドロキシベンゾイル]-2-[(3-ヒドロキシ-1,2-ベンズイソオキサゾール-6-イル)メトキシ]フェニル}プロピオン酸またはその塩を含有する固体分散体またはその組成物 |
JP5615554B2 (ja) * | 2007-11-27 | 2014-10-29 | 富山化学工業株式会社 | 3−{5−[4−(シクロペンチルオキシ)−2−ヒドロキシベンゾイル]−2−[(3−ヒドロキシ−1,2−ベンズイソオキサゾール−6−イル)メトキシ]フェニル}プロピオン酸またはその塩を含有する固体分散体の組成物 |
WO2009119652A1 (ja) | 2008-03-27 | 2009-10-01 | 富山化学工業株式会社 | ベンゾフェノン誘導体またはその塩およびTNFα阻害剤を組み合わせて使用する方法ならびにこれらを含有する医薬組成物 |
JP5512510B2 (ja) * | 2008-03-27 | 2014-06-04 | 富山化学工業株式会社 | ベンゾフェノン誘導体またはその塩およびTNFα阻害剤を組み合わせて使用する方法ならびにこれらを含有する医薬組成物 |
RU2522272C2 (ru) * | 2008-03-27 | 2014-07-10 | Тояма Кемикал Ко., Лтд. | ПРИМЕНЕНИЕ БЕНЗОФЕНОНОВОГО ПРОИЗВОДНОГО ИЛИ ЕГО СОЛИ И ИНГИБИТОРА TNF-α В КОМБИНАЦИИ, И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ДАННОЕ ПРОИЗВОДНОЕ ИЛИ ЕГО СОЛЬ И ИНГИБИТОР |
RU2496490C2 (ru) * | 2008-04-22 | 2013-10-27 | Тояма Кемикал Ко., Лтд. | Способ применения комбинации производного бензофенона или его соли и иммуносупрессора и фармацевтическая композиция, содержащая данные компоненты |
US9066977B2 (en) | 2008-04-22 | 2015-06-30 | Toyama Chemical Co., Ltd. | Method of utilization of combination of benzophenone derivative or salt thereof and immunosuppressing agent, and pharmaceutical composition comprising these components |
JP5512511B2 (ja) * | 2008-04-22 | 2014-06-04 | 富山化学工業株式会社 | ベンゾフェノン誘導体またはその塩および免疫抑制剤を組み合わせて使用する方法ならびにこれらを含有する医薬組成物 |
WO2009131098A1 (ja) | 2008-04-22 | 2009-10-29 | 富山化学工業株式会社 | ベンゾフェノン誘導体またはその塩および免疫抑制剤を組み合わせて使用する方法ならびにこれらを含有する医薬組成物 |
JP2014166984A (ja) * | 2008-04-22 | 2014-09-11 | Toyama Chem Co Ltd | ベンゾフェノン誘導体またはその塩および免疫抑制剤を組み合わせて使用する方法ならびにこれらを含有する医薬組成物 |
US8772293B2 (en) | 2010-07-09 | 2014-07-08 | Pfizer Limited | Chemical compounds |
US8592629B2 (en) | 2010-07-12 | 2013-11-26 | Pfizer Limited | Sulfonamide derivatives as Nav 1.7 inhibitors |
US8685977B2 (en) | 2010-07-12 | 2014-04-01 | Pfizer Limited | Chemical compounds |
WO2014157623A1 (ja) * | 2013-03-29 | 2014-10-02 | 富山化学工業株式会社 | ベンゾフェノン誘導体またはその塩を含有する肺高血圧症治療薬 |
JPWO2014157623A1 (ja) * | 2013-03-29 | 2017-02-16 | 塩澤 俊一 | ベンゾフェノン誘導体またはその塩を含有する肺高血圧症治療薬 |
Also Published As
Publication number | Publication date |
---|---|
US20050113400A1 (en) | 2005-05-26 |
NO20042495L (no) | 2004-08-11 |
BR0214177A (pt) | 2004-09-14 |
HUP0402025A3 (en) | 2006-01-30 |
CN1602291A (zh) | 2005-03-30 |
DK1445249T3 (da) | 2012-12-17 |
JP4554926B2 (ja) | 2010-09-29 |
EP1445249A4 (en) | 2006-03-08 |
AU2002349777B2 (en) | 2007-12-20 |
EP1445249B1 (en) | 2012-11-07 |
PT1445249E (pt) | 2013-01-16 |
RO123430B1 (ro) | 2012-04-30 |
CA2467261C (en) | 2010-10-12 |
HUP0402025A2 (hu) | 2005-02-28 |
US7772285B2 (en) | 2010-08-10 |
ZA200403373B (en) | 2006-01-25 |
IL161736A0 (en) | 2005-11-20 |
CA2467261A1 (en) | 2003-05-22 |
CN1602291B (zh) | 2010-05-12 |
ES2394963T3 (es) | 2013-02-07 |
NO329094B1 (no) | 2010-08-23 |
PL206100B1 (pl) | 2010-06-30 |
KR20050044458A (ko) | 2005-05-12 |
PL370224A1 (en) | 2005-05-16 |
CY1113657T1 (el) | 2016-06-22 |
KR100947253B1 (ko) | 2010-03-11 |
EP1445249A1 (en) | 2004-08-11 |
JPWO2003042150A1 (ja) | 2005-04-07 |
MXPA04004654A (es) | 2005-05-17 |
NZ532810A (en) | 2005-03-24 |
IL161736A (en) | 2008-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003042150A1 (fr) | Nouveaux derives de benzophenone ou sels de ceux-ci | |
UA102336C2 (uk) | N1-ПІРАЗОЛСПІРОКЕТОНИ ЯК ІНГІБІТОРИ АЦЕТИЛ-СоА-КАРБОКСИЛАЗ | |
NO20024424D0 (no) | Glykopyranosyloksybenzylbenzenderivater, medisinske sammensetninger inneholdende slike, samt intermediater tilfremstilling av derivatene | |
RS20090249A (en) | Spiroketone acetyl-coa carboxylase inhibotors | |
BG106451A (en) | Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof | |
TW200734314A (en) | Piperazine compounds having herbicidal action | |
WO2001019798A3 (en) | Inhibitors of factor xa | |
WO2008012635A3 (en) | Amine derivatives useful as anticancer agents | |
WO2007106192A3 (en) | Inhibitors of iap | |
TNSN06411A1 (en) | Pyrimidine urea derivatives as kinase inhibitors | |
NO20070557L (no) | Ftalazinderivater som PARP-inhibitorer | |
MY147786A (en) | Substituted morpholine and thiomorpholine derivatives | |
PL1685142T3 (pl) | Pochodne kwasu fosfinowego, inhibitory beta-sekterazy do leczenia choroby Alzheimera | |
WO2007125310A3 (en) | Pharmaceutical combinations of pk inhibitors and other active agents | |
IL189017A0 (en) | 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-effective agents | |
WO2007126900A3 (en) | Antifungal agents | |
ZA200704913B (en) | 3-[2-(3-acylamino-2-oxo-2H-pyridin-1-YL)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors | |
PL1682528T3 (pl) | Pochodne benzo[b][1,4]dioksepiny | |
IL185164A0 (en) | New isothiazoloquinolones and related compounds as anti-infective agents | |
WO2009015369A3 (en) | Isophthalamide derivatives inhibiting beta-secretase activity | |
WO2007138112A3 (en) | Compounds that interact with ion channels, in particular with ion channels from the kv family | |
PL367511A1 (en) | Selective herbicides based on substituted thien-3-yl-sulfonylamino(thio)carbonyl-triazolin(thi)ones and safeners | |
WO2007027878A3 (en) | 4-substituted 2-aryloxyphenol derivatives as antibacterial agents | |
HK1041264A1 (en) | Imidazole compounds and their use as adenosine deaminase inhibitors | |
MX2009005912A (es) | Derivados de etilamina-fenilo heterociclilo sustituidos, su preparacion y uso como medicamentos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002349777 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 161736 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004/03373 Country of ref document: ZA Ref document number: 200403373 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 00591/KOLNP/2004 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 532810 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002781763 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020047007327 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 2004 200400442 Country of ref document: RO Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2004/004654 Country of ref document: MX Ref document number: 2467261 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20028248120 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2002781763 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003543987 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10493223 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 532810 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 532810 Country of ref document: NZ |
|
ENP | Entry into the national phase |
Ref document number: 2002349777 Country of ref document: AU Date of ref document: 20021113 Kind code of ref document: B |